The future of skin science. Fits in a lipid.

Read more about AKVANO®

Pharma solutions

We create new opportunities in skin science

Lipidor develops pharmaceuticals for skin with unique lipid based formulation opportunities for global pharma companies. Our proprietary delivery platform and expertise help pharma companies launch innovative, patient-friendly skin treatments, in record time.

Our pharma solutions

Introduction

What makes Lipidor unique?

Our innovative and flexible delivery system AKVANO® brings a number of tangible benefits for pharmaceutical companies and patients alike.

Company

This is Lipidor

Lipidor is a Swedish, Stockholm-based research and development company with a pipeline of pharmaceutical development projects in pre-clinical and clinical phases.

Get to know Lipidor

Lipidor update

Letter from our CEO

A couple of weeks ago, we announced to the market the very good news that Lipidor has secured funding for a Phase III study of our drug candidate for psoriasis. With financing in place, it’s time to proceed at full speed with operational activities. All focus is now on conducting a Phase III study with our drug candidate AKP02G2, with the aim of presenting study results as early as the end of Q1 2025.

Read the full letter

Business scope

Targeting the future of pharmaceuticals for skin

The global demand for pharmaceuticals for skin is a large and growing market. With the revolutionary AKVANO® delivery platform, Lipidor is at the cutting-edge of innovation. Want to know more?

Read more